about
Coriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expressionEfficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancerIn vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation.High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.The Effect of Essential Oils and Bioactive Fractions on Streptococcus mutans and Candida albicans Biofilms: A Confocal Analysis.A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans.Photodynamic therapy of oral Candida infection in a mouse model.An In Vitro Model for Oral Mixed Biofilms of Candida albicans and Streptococcus gordonii in Synthetic SalivaInhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsRepurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.Targeting Candida albicans filamentation for antifungal drug development.The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.Learning the ABC of oral fungal drug resistance.Future therapies targeted towards eliminating Candida biofilms and associated infections.Fungal Biofilms: Update on Resistance.Strategies in the discovery of novel antifungal scaffolds.The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.Antibiofilm and Antihyphal Activities of Cedar Leaf Essential Oil, Camphor, and Fenchone Derivatives against Candida albicans.Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans.New strategic insights into managing fungal biofilmsTrichosporon asahii Infection in a Patient with Metastatic Prostate Cancer as an Example of an Emerging Fungal Pathogen.In vitro inhibitory activity of terpenic derivatives against clinical and environmental strains of the Sporothrix schenkii complex.New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis.Nectar yeasts of the Metschnikowia clade are highly susceptible to azole antifungals widely used in medicine and agriculture.Biofilms and beyond: expanding echinocandin utility.Antifungal Compounds against Candida Infections from Traditional Chinese Medicine.Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms.Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs.Effect of Blume Essential Oil on spp. Involved in Oral Infections(1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition
P2860
Q28539436-C8B81C00-A3DA-493F-B5F0-EE6A907379EBQ33798097-F2860E2A-7AC3-45BF-9550-ABB0887F12F9Q34298898-5B9BA705-6AA3-4B17-9541-000C35A226B3Q35119312-3A60DA28-E5BF-43BA-B4B0-89FA83AD00A1Q35188272-45C0A90E-E389-46A3-B657-BFDB911E705CQ35874892-1698D212-6A94-4436-9C56-B684120BCB1FQ35961258-046C57EB-4453-4595-B6B9-64972ACFFAF1Q35988608-C8EA174B-07E1-4FF0-85C5-36062E186616Q36034513-E9A4EFD9-178C-4166-919E-65DE82EA6DCAQ36267962-CFDB38DC-230D-44A6-87F8-B364411E81E2Q36370400-F4FA021A-56A5-4150-A8E1-3A8C1065C911Q36422270-64AD9C88-8851-48B2-99BA-A7119A4304A2Q37705305-667FA5FD-09CA-4A9A-8A6F-DEC9757B0889Q37705311-AC8596CF-BA9D-4DD5-BF0F-AE842D559F29Q38412398-C7ACE374-FE06-4D45-9020-DCF2C627F2A8Q38515541-DF9FE4B7-926B-44AE-A574-9D375B71F6A7Q38786061-E7D407D5-A170-4DE2-8CD7-1B2F3B104810Q38817837-DF5BAA72-4F8F-41FF-BE8D-B1E6F62D6D20Q38837363-D05E12C7-9882-4044-8B1A-9B67096299ABQ39233357-CAA2CAB1-4845-413F-8E8F-A7420D61AFD5Q40086401-A685DC09-E6E4-43E0-BEE3-FFADE1FA5184Q40347601-16C1506E-D9F5-4DC3-8E5A-FAD8A1D4641BQ40937754-4565637C-F5D0-4DA3-B996-F2843D311CAEQ40982758-625024D5-DEE8-4C19-B654-3B45EF29D641Q41581033-969B67F0-E572-46B1-B793-D6AEA5759A4DQ46244030-E4B24E0F-60C7-4E70-85AE-D14182DA8A5EQ46250284-E6297EBA-32D9-45D4-9E5E-5F37A2FF6921Q46295052-2B983FA6-D57C-42EE-BD89-C71EE152A374Q46619016-2647B74F-476B-44DE-91C7-88DCD3074DF9Q47205366-B7148A17-0A30-4E12-B39F-3B2074BFDA39Q49507389-E2CAEE48-6FF5-419A-B25F-76EEF5B06D27Q55096310-9F3D83BD-5628-49DD-B91C-A29BDCF4E3CFQ55516936-F8C96E2C-CF7B-42F2-9188-45F6B9351AEAQ58695534-9C24EFAF-DC30-4B8F-8A1D-5D52C6E4223FQ58728605-0B652544-6B3A-4A66-B7EE-9746B0A9EDB7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifungal therapy with an emphasis on biofilms
@en
Antifungal therapy with an emphasis on biofilms.
@nl
type
label
Antifungal therapy with an emphasis on biofilms
@en
Antifungal therapy with an emphasis on biofilms.
@nl
prefLabel
Antifungal therapy with an emphasis on biofilms
@en
Antifungal therapy with an emphasis on biofilms.
@nl
P2093
P2860
P1476
Antifungal therapy with an emphasis on biofilms
@en
P2093
Anand K Ramasubramanian
Anand Srinivasan
Christopher G Pierce
José L López-Ribot
Priya Uppuluri
P2860
P304
P356
10.1016/J.COPH.2013.08.008
P577
2013-09-04T00:00:00Z